{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:44:41Z","timestamp":1793371481587,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.neurol.2022.01.007","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T01:01:33Z","timestamp":1643936493000},"page":"675-691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Medical treatment of Rasmussen's Encephalitis: A systematic review"],"prefix":"10.1016","volume":"178","author":[{"given":"S.","family":"Lagarde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Boucraut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bartolomei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2022.01.007_bib0450","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1474-4422(13)70260-6","article-title":"Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances","volume":"13","author":"Varadkar","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0455","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.seizure.2020.07.023","article-title":"Rasmussen's encephalitis: from immune pathogenesis towards targeted- therapy","volume":"81","author":"Orsini","year":"2020","journal-title":"Seizure Eur J Epilepsy"},{"key":"10.1016\/j.neurol.2022.01.007_bib0460","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/brain\/awf176","article-title":"The natural history of Rasmussen's encephalitis","volume":"125","author":"Bien","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.01.007_bib0465","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.autrev.2017.05.022","article-title":"Late-onset Rasmussen Encephalitis: a literature appraisal","volume":"16","author":"Dupont","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.neurol.2022.01.007_bib0470","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/brain\/awp003","article-title":"CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery","volume":"132","author":"Schwab","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.01.007_bib0475","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/brain\/awh415","article-title":"Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement","volume":"128","author":"Bien","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.01.007_bib0480","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/j.1528-1167.2008.01977.x","article-title":"A substantial number of Rasmussen syndrome patients have increased IgG, CD4+ T cells, TNF\u03b1, and Granzyme B in CSF","volume":"50","author":"Takahashi","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2022.01.007_bib0485","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1528-1167.2006.00569.x","article-title":"Proposed criteria for referral and evaluation of children for epilepsy surgery: Recommendations of the subcommission for pediatric epilepsy surgery","volume":"47","author":"Cross","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2022.01.007_bib0490","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2015.07.044","article-title":"Language recovery after left hemispherotomy for Rasmussen encephalitis","volume":"53","author":"Bulteau","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neurol.2022.01.007_bib0495","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3171\/2019.9.PEDS19380","article-title":"Seizure outcomes in children with Rasmussen's encephalitis undergoing resective or hemispheric epilepsy surgery: an individual participant data meta-analysis","volume":"25","author":"Harris","year":"2020","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.neurol.2022.01.007_bib0500","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.0013-9580.2004.33103.x","article-title":"The pathology of rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies","volume":"45","author":"Pardo","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2022.01.007_bib0505","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.10100","article-title":"Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis","volume":"51","author":"Bien","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0510","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.21148","article-title":"Astrocytes are a specific immunological target in Rasmussen's encephalitis","volume":"62","author":"Bauer","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2016.00064","article-title":"Evidence for resident memory T cells in Rasmussen encephalitis","volume":"7","author":"Owens","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0520","doi-asserted-by":"crossref","first-page":"11153","DOI":"10.1038\/ncomms11153","article-title":"CD8+T-cell pathogenicity in Rasmussen encephalitis elucidated by large-scale T-cell receptor sequencing","volume":"7","author":"Schneider-Hohendorf","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurol.2022.01.007_bib0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-10-56","article-title":"Differential expression of interferon-\u03b3 and chemokine genes distinguishes Rasmussen encephalitis from cortical dysplasia and provides evidence for an early Th1 immune response","volume":"10","author":"Owens","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurol.2022.01.007_bib0530","first-page":"5","article-title":"Phenotypic and functional complexity of brain-infiltrating T cells in Rasmussen encephalitis","author":"Al Nimer","year":"2018","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"key":"10.1016\/j.neurol.2022.01.007_bib0535","first-page":"12","article-title":"Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis","author":"Owens","year":"2015","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurol.2022.01.007_bib0540","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1186\/1742-2094-10-152","article-title":"Inflammasome induction in Rasmussen's encephalitis: cortical and associated white matter pathogenesis","volume":"10","author":"Ramaswamy","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurol.2022.01.007_bib0545","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0550","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.8036512","article-title":"Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis","volume":"265","author":"Rogers","year":"1994","journal-title":"Science (80-)"},{"key":"10.1016\/j.neurol.2022.01.007_bib0555","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0896-6273(00)00118-5","article-title":"Autoimmunity to Munc-18 in Rasmussen's encephalitis","volume":"28","author":"Yang","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neurol.2022.01.007_bib0560","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1212\/01.wnl.0000191566.86977.04","article-title":"\u03b17-Acetylcholine receptor antibodies in two patients with Rasmussen encephalitis","volume":"65","author":"Watson","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0565","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejpn.2015.12.011","article-title":"Antibodies to AMPA receptors in Rasmussen's encephalitis","volume":"20","author":"Nibber","year":"2016","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0570","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1523\/JNEUROSCI.1510-05.2005","article-title":"Modulator effects of interleukin-1\u03b2 and tumor necrosis factor-\u03b1 on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures","volume":"25","author":"Bernardino","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2022.01.007_bib0575","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1523\/JNEUROSCI.4486-04.2005","article-title":"Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-\u03b1","volume":"25","author":"Stellwagen","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2022.01.007_bib0580","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1172\/JCI97098","article-title":"Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis","volume":"128","author":"Kebir","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurol.2022.01.007_bib0585","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1212\/NXI.0000000000000069","article-title":"Rasmussen encephalitis: response to early immunotherapy in a case of immune-mediated encephalitis","volume":"2","author":"Liba","year":"2015","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"key":"10.1016\/j.neurol.2022.01.007_bib0590","series-title":"Comparison of the real world effectiveness of vertical versus-lateral functional hemispherotomy techniques for pediatric drug resistant-epilepsy: A post-hoc analysis of the HOPS study","author":"Fallah","year":"2021"},{"key":"10.1016\/j.neurol.2022.01.007_bib0595","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1111\/epi.17111","article-title":"Vertical hemispherotomy for drug-resistant epilepsy: toward confirmation of the HOPS study","volume":"62","author":"Bourdillon","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2022.01.007_bib0600","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/1531-8249(199910)46:4<579::AID-ANA5>3.0.CO;2-K","article-title":"Language recovery after left hemispherectomy in children with late-onset seizures","volume":"46","author":"Boatman","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0605","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/brain\/awf020","article-title":"Late plasticity for language in a child's non-dominant hemisphere: a pre- and post-surgery fMRI study","volume":"125","author":"Hertz-Pannier","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2022.01.007_bib0610","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10143-015-0623-5","article-title":"Epilepsy surgery in adult-onset Rasmussen's encephalitis: case series and review of the literature","volume":"38","author":"Casciato","year":"2015","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.neurol.2022.01.007_bib0615","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2017.10.010","article-title":"Therapeutic mechanisms of Glucocorticoids","volume":"29","author":"Vandewalle","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.neurol.2022.01.007_bib0620","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids--new mechanisms for old drugs","volume":"353","author":"T.R.","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2022.01.007_bib0625","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.seizure.2007.03.002","article-title":"Long term response to steroid therapy in Rasmussen encephalitis","volume":"16","author":"Bahi-Buisson","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.neurol.2022.01.007_bib0630","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.braindev.2013.01.010","article-title":"Immunomodulatory therapy versus surgery for Rasmussen syndrome in early childhood","volume":"35","author":"Takahashi","year":"2013","journal-title":"Brain Dev"},{"key":"10.1016\/j.neurol.2022.01.007_bib0635","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1136\/jnnp.57.11.1325","article-title":"Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids","volume":"57","author":"Chinchilla","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2022.01.007_bib0640","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1212\/WNL.44.6.1030","article-title":"Medical treatment of rasmussen's syndrome (chronic encephalitis and epilepsy: effect of high)dose steroids or immunoglobulins in 19 patients","volume":"44","author":"Hart","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0645","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1212\/01.WNL.0000099074.04539.E0","article-title":"Experience with immunomodulatory treatments in Rasmussen's encephalitis","volume":"61","author":"Granata","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0650","article-title":"Immunomodulation with Azathioprine therapy in Rasmussen syndrome: a multimodal evaluation","volume":"96","author":"Pellegrin","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0655","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1084\/jem.20061788","article-title":"The antiinflammatory activity of IgG: the intravenous IgG paradox","volume":"204","author":"Nimmerjahn","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.neurol.2022.01.007_bib0660","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nrneurol.2014.253","article-title":"Intravenous immunoglobulin in neurology\u2014mode of action and clinical efficacy","volume":"11","author":"L\u00fcnemann","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0665","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0887-8994(96)00016-1","article-title":"Rasmussen syndrome and long-term response to gamma globulin","volume":"14","author":"Wise","year":"1996","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0670","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1212\/WNL.52.4.738","article-title":"Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy","volume":"52","author":"Leach","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0675","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1212\/WNL.56.2.248","article-title":"Positive response to immunomodulatory therapy in a adult patient with Rasmussen's encephalitis","volume":"56","author":"Villani","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0680","first-page":"204","article-title":"Treatment of Rasmussen's syndrome with intra- venous gammaglobulin","author":"P.W.","year":"1991","journal-title":"Chronic Enceph epilepsy Rasm Syndr"},{"key":"10.1016\/j.neurol.2022.01.007_bib0685","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.seizure.2013.02.003","article-title":"Rasmussen syndrome: An Argentinean experience in 32 patients","volume":"22","author":"Caraballo","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.neurol.2022.01.007_bib0690","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1212\/WNL.46.1.242","article-title":"Plasmapheresis in Rasmussen's encephalitis","volume":"46","author":"Andrews","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0695","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1744-9987.1997.tb00019.x","article-title":"Plasma exchange in Rasmussen's encephalitis","volume":"1","author":"Palcoux","year":"1997","journal-title":"Ther Apher"},{"key":"10.1016\/j.neurol.2022.01.007_bib0700","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.51.1.302","article-title":"Long-term selective IgG immunoadsorption improves Rasmussen's encephalitis","volume":"51","author":"Antozzi","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0705","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nrneurol.2009.98","article-title":"A case of Rasmussen encephalitis treated with rituximab","volume":"5","author":"Thilo","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0710","doi-asserted-by":"crossref","first-page":"159","DOI":"10.33588\/rn.7004.2019439","article-title":"Inmunoadsorci\u00f3n y plasmaf\u00e9resis: \u00bfposibilidades de tratamiento en la encefalitis de Rasmussen?","volume":"70","author":"Cantar\u00edn-Extremera","year":"2020","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0715","first-page":"179","article-title":"Long-term effect of rituximab in a case with Late-onset Rasmussen's encephalitis with anti-ganglioside IgGQlb and anti-GAD antibodies positivity","volume":"37","author":"Tim\u00e1rov\u00e1","year":"2016","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.neurol.2022.01.007_bib0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2017.00564","article-title":"A case series of adult-onset Rasmussen's Encephalitis: diagnostic and therapeutic challenges","volume":"8","author":"Castellano","year":"2017","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0725","doi-asserted-by":"crossref","first-page":"100360","DOI":"10.1016\/j.ebr.2020.100360","article-title":"Posterior-onset Rasmussen's encephalitis with ipsilateral cerebellar atrophy and uveitis resistant to rituximab","volume":"14","author":"Sansevere","year":"2020","journal-title":"Epilepsy Behav Reports"},{"key":"10.1016\/j.neurol.2022.01.007_bib0730","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1111\/ene.13795","article-title":"Adult-onset Rasmussen encephalitis treated with mitoxantrone","volume":"25","author":"Stabile","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0735","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1212\/WNL.0000000000000791","article-title":"Rasmussen encephalitis comorbid autoimmune diseases: a window into disease mechanism?","volume":"83","author":"Amrom","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0740","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.yebeh.2017.06.027","article-title":"Can head trauma trigger adult-onset Rasmussen\u2019s encephalitis?","volume":"74","author":"Soh","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neurol.2022.01.007_bib0745","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1212\/01.WNL.0000128044.94294.87","article-title":"An open study of tacrolimus therapy in Rasmussen encephalitis","volume":"62","author":"Bien","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0750","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/epi.12042","article-title":"Rasmussen encephalitis: Incidence and course under randomized therapy with tacrolimus or intravenous immunoglobulins","volume":"54","author":"Bien","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2022.01.007_bib0755","first-page":"4","article-title":"Alemtuzumab and intrathecal methotrexate failed in the therapy of Rasmussen encephalitis","author":"Liba","year":"2017","journal-title":"Neurol Neuroimmunol NeuroInflammation"},{"key":"10.1016\/j.neurol.2022.01.007_bib0760","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00381-008-0795-1","article-title":"Rasmussen encephalitis: Long-term outcome after surgery","volume":"25","author":"Terra-Bustamante","year":"2009","journal-title":"Child's Nerv Syst"},{"key":"10.1016\/j.neurol.2022.01.007_bib0765","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1212\/WNL.0b013e31829c5ceb","article-title":"Rasmussen encephalitis treated with natalizumab","volume":"81","author":"Bittner","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0770","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/epi.13387","article-title":"Anti-tumor necrosis factor alpha therapy (adalimumab) in Rasmussen's encephalitis: an open pilot study","volume":"57","author":"Lagarde","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2022.01.007_bib0775","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.braindev.2009.10.004","article-title":"Nationwide survey (incidence, clinical course, prognosis) of Rasmussen's encephalitis","volume":"32","author":"Muto","year":"2010","journal-title":"Brain Dev"},{"key":"10.1016\/j.neurol.2022.01.007_bib0780","first-page":"1","article-title":"Rasmussen's Encephalitis: a report of a tunisian pediatric case and literature review","volume":"2020","author":"Klaa","year":"2020","journal-title":"Case Rep Neurol Med"},{"key":"10.1016\/j.neurol.2022.01.007_bib0785","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.seizure.2019.08.001","article-title":"Rasmussen's encephalitis presenting as progressive parietal dysfunction sans seizures","volume":"71","author":"Garg","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.neurol.2022.01.007_bib0790","doi-asserted-by":"crossref","first-page":"100334","DOI":"10.1016\/j.ebr.2019.100334","article-title":"Efficacy and tolerability of mycophenolate mofetil in a pediatric Rasmussen syndrome","volume":"13","author":"Orsini","year":"2020","journal-title":"Epilepsy Behav Reports"},{"key":"10.1016\/j.neurol.2022.01.007_bib0795","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clim.2008.01.011","article-title":"cell depletion in autoimmune diseases: potential effects on T cells","volume":"127","author":"Liossis","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0800","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.seizure.2016.09.009","article-title":"Adult onset Rasmussen's encephalitis associated with reflex language induced seizures responsive to Rituximab therapy","volume":"42","author":"El Tawil","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.neurol.2022.01.007_bib0805","first-page":"9","article-title":"Pilot study of rituximab Tto treat chronic focal encephalitis","author":"Laxer","year":"2008","journal-title":"AES 2008"},{"key":"10.1016\/j.neurol.2022.01.007_bib0810","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1212\/01.wnl.0000267429.89675.03","article-title":"Rasmussen syndrome and CNS granulomatous disease with NOD2\/CARD15 mutations","volume":"69","author":"Goyal","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0815","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.bbi.2011.03.018","article-title":"IL-1 receptor\/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures","volume":"25","author":"Vezzani","year":"2011","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurol.2022.01.007_bib0820","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.20358","article-title":"Interleukin-1\u03b2 contributes to the generation of experimental febrile seizures","volume":"57","author":"Dub\u00e9","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0825","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1523\/JNEUROSCI.19-12-05054.1999","article-title":"Interleukin-1\u03b2 immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures","volume":"19","author":"Vezzani","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurol.2022.01.007_bib0830","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2016.12.007","article-title":"Blockade of the IL-1R1\/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy","volume":"99","author":"Iori","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2022.01.007_bib0835","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1073\/pnas.190206797","article-title":"Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice","volume":"97","author":"Vezzani","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurol.2022.01.007_bib0840","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1684\/epd.2021.1283","article-title":"Super-refractory status epilepticus in autoimmune encephalitis treated with interleukin-1 receptor antagonist, anakinra","volume":"23","author":"Choi ho","year":"2021","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.neurol.2022.01.007_bib0845","first-page":"16","article-title":"Seizure control after late introduction of anakinra in a patient with adult onset Rasmussen's encephalitis","author":"Mochol","year":"2021","journal-title":"Epilepsy Behav Reports"},{"key":"10.1016\/j.neurol.2022.01.007_bib0850","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12883-020-01932-9","article-title":"An immunotherapy effect analysis in Rasmussen encephalitis","volume":"20","author":"Liba","year":"2020","journal-title":"BMC Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0855","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1212\/WNL.46.1.247","article-title":"Chronic steroid-responsive encephalitis without autoantibodies to glutamate receptor GluR3","volume":"46","author":"Krauss","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0860","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/WNL.47.4.925","article-title":"Treatment of Rasmussen's syndrome with ganciclovir","volume":"47","author":"McLachlan","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2022.01.007_bib0865","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1017\/S0317167100011495","article-title":"Early treatment of a progressive rasmussen's like syndrome with ganciclovir","volume":"38","author":"McLachlan","year":"2011","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.neurol.2022.01.007_bib0870","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1528-1157.1994.tb02443.x","article-title":"Partially successful treatment of rasmussen's encephalitis with zidovudine: symptomatic improvement followed by involvement of the contralateral hemisphere","volume":"35","author":"DeToledo","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2022.01.007_bib0875","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/S0317167100048277","article-title":"Intraventricular alpha interferon therapy for Rasmussen's syndrome","volume":"20","author":"Bernard","year":"1993","journal-title":"Can J Neurol Sci\/J Can Des Sci Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0880","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1528-1157.1997.tb01491.x","article-title":"Intraventricular interferon-\u03b1 stops seizures in Rasmussen's encephalitis: a case report","volume":"38","author":"Dabbagh","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2022.01.007_bib0885","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0887-8994(03)00216-9","article-title":"Rasmussen syndrome and long-term response to thalidomide","volume":"29","author":"Marjanovic","year":"2003","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.neurol.2022.01.007_bib0890","first-page":"2020","article-title":"Intrathecal infusion of autologous adipose-derived regenerative cells in autoimmune refractory epilepsy: evaluation of safety and efficacy","author":"Szczepanik","year":"2020","journal-title":"Stem Cells Int"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378722000352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378722000352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:44:15Z","timestamp":1758519855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378722000352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":89,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0035378722000352"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2022.01.007","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical treatment of Rasmussen's Encephalitis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2022.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}